Oral and Poster Abstract Submission Guidelines

Please review the guidelines below carefully before

submitting your abstract.

SUBMISSION INSTRUCTIONS

  • Abstracts shall be submitted electronically through the Congress website.
  • The abstract must be written in English.
  • The word count for abstracts for is limited to 2,500 characters.
  • One table and/or one image may be included in the abstract and will count as one word each in your word count.
  • Tables/images must be placed at the end of your abstract.
  • Abstracts which have been previously presented at national or international meetings can be submitted to E-AHPBA.
  • Abstracts which have been previously presented at E-AHPBA should not be re-submitted.
  • In relation to clinical work, it is encouraged that all work should have been reviewed and approved by institutional or regional ethics boards and that all co-authors must be familiar with the final submitted abstract.
  • In relation to basic science work, it is obligatory to provide a statement in the text of the abstract confirming ethics committee review of the work.
  • Case reports are not specifically excluded; however, the rejection rate of case reports is high. A case report should only be submitted if it represents a genuine advance in knowledge.
  • When you submit an abstract online, your abstract will automatically be formatted according to the E-AHPBA 2027 Congress submission requirements.

ABSTRACT STRUCTURE


Abstracts should be structured in the following four sections (case study abstracts do not need to follow this structure):

INTRODUCTION

Indicated the purpose of the study.

METHODS

Describes pertinent experimental procedures.

RESULTS

Summarises the results of the research.

RESULTS

States the main conclusions.

GENERAL INFORMATION

  • Presenters are permitted to submit a maximum of two abstracts for Oral Presentations.
  • There is no limit to the number of Poster Presentations an author may submit.
  • Authors should select one topic only for each abstract submitted. If an abstract relates to more than one topic, please select the most appropriate: Liver, Pancreas, Biliary, Transplant or HPB 360.
  • It is the submitting author’s responsibility to submit a correct abstract. Any errors in spelling, grammar or scientific fact will be published as typed by the author, if accepted. Poor English may be a cause for rejection.
  • If the submission process is not completed, the abstract will remain in draft until the author returns to complete the submission. Abstracts must be fully submitted by 7 January 2027 (23:59hrs CET) to be considered.
  • Changes to abstracts may be made until 7 January 2027 through the submitting author’s personal 'My Submissions' page.
  • The submitting author will receive all correspondence concerning the abstract and is responsible for informing the other authors of its status.
  • An acknowledgement of submission will be sent to the email address provided. If confirmation is not received within 24 hours, please contact the Abstract Department at eahpba.abstracts@abstractserver.com.
  • Notification of acceptance/rejection will be emailed to the submitting author from 16 March 2027 onwards.
  • Specifications for Oral and Poster Presentations will be made available on the website and forwarded with the abstract acceptance.
  • Upon acceptance, presenting authors are expected to register and present their abstract in person at the Congress.
  • Accepted abstracts will be published in the online Congress supplement of E-AHPBA’s official partner journal, HPB, subject to the presenting author meeting the required registration and payment deadline of 22 April 2027.
  • Presenting authors not registered and paid by 22 April 2027 may have their abstracts removed from the Book of Abstracts.
  • For Oral Presentations, E-AHPBA encourages manuscript submission to HPB, although this is not mandatory and publication is not guaranteed.

For further information:

European-African Hepato-Pancreato-Biliary Association (E-AHPBA) Biennial Congress 2027


© 2026 E-AHPBA. All rights reserved.